PDS Biotech publishes phase 2 head and neck cancer trial results

September 22, 2026 8:00 AM

PDS Biotechnology Corporation (Nasdaq: PDSB) announced the publication of results from its VERSATILE-002 phase 2 clinical trial in the September ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found